Annotation Detail for ENOPH1

Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa00270 | Cysteine and methionine metabolism |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of ENOPH1 mRNA | increases expression | 20106945
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ENOPH1 mRNA] | affects reaction|increases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of ENOPH1 mRNA | increases expression | 19482888
|
D019772 |
Topotecan |
ENOPH1 protein affects the susceptibility to Topotecan | affects response to substance | 16217747
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
4.18 | 6195326 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
4.71 | 17620307 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
1.95 | 17173139 20007298 1701930 6705139 20935162 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.82 | 12371664 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.90 | 4080065 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.24 | 19486331 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
4.53 | 1851702 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.76 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
4.74 | 11558140 3922381 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
3.08 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.96 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.90 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
4.76 | 3659116 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.34 | 19224547 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.79 | 12639820 12168785 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.96 | 8708960 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
5.16 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
4.13 | 16109766 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.23 | 10903974 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.31 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.56 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.12 | 12371664 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
3.10 | 21047994 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
2.25 | 19363144 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
2.43 | 19812893 8742319 19482888 15975961 21047994 19073162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
2.95 | 6150874 1399818 2563599 17172636 18308698 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.65 | 16801185 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
5.22 | 17484760 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.31 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.70 | 18481113 19348381 |
MESH:D009447 |
Neuroblastoma |
|
Topotecan |
4.04 | 15176712 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
5.11 | 17016548 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
2.61 | 16965848 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
10.38 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
10.38 | 2563599 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
5.36 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.34 | 16882103 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
2.97 | 3137016 16876388 11442880 4039156 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
5.56 | 6407741 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
3.39 | 1399818 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.85 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.31 | 17120751 |
Pathway ID |
Pathway Name |
---|
KEGG:00270 |
Cysteine and methionine metabolism |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB07912 |
- |
2-OXOHEPTYLPHOSPHONIC ACID |
|